Genomic test helps estimate risk of prostate cancer metastasis, death ...Middle East

- News
Genomic test helps estimate risk of prostate cancer metastasis, death
A commercially available genomic test may help oncologists better determine which patients with recurrent prostate cancer may benefit from hormone therapy, according to new research from the Johns Hopkins Kimmel Cancer Center and 15 other medical centers.

Hence then, the article about genomic test helps estimate risk of prostate cancer metastasis death was published today ( ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Genomic test helps estimate risk of prostate cancer metastasis, death )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News